Jason Mock
Affiliations: | 2009-2012 | Pharmaceuitcal and Biomedical Sciences | University of Georgia, Athens, Athens, GA, United States |
Google:
"Jason Mock"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Robert D. Arnold | grad student | 2009-2012 | University of Georgia | |
| (co/Advised with Dr. Cummings, ? Dissertation Title: Phospholipase A2 as Therapeutic Targets in Prostate Cancer) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Quach ND, Mock JN, Scholpa NE, et al. (2014) Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells Molecular Pharmaceutics. 11: 3443-3451 |
| Mock JN, Costyn LJ, Wilding SL, et al. (2013) Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer Integrative Biology (United Kingdom). 5: 172-182 |
| Mock JN, Taliaferro JP, Lu X, et al. (2012) Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer Bioorganic and Medicinal Chemistry Letters. 22: 4854-4858 |
| Aljuffali IA, Mock JN, Costyn LJ, et al. (2011) Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer. Cancer Biology & Therapy. 12: 407-20 |
| Zhu G, Mock JN, Aljuffali I, et al. (2011) Secretory phospholipase A 2 responsive liposomes Journal of Pharmaceutical Sciences. 100: 3146-3159 |